DLL4 and cancer: The activated TF AHR can upregulate the expression of target gene DLL4 and activate the Notch signaling pathway, which can lead to tube formation in cancer cells, increase blood vessel branching, reduce pericyte recruitment, and reduce fibronectin expression [65].